Vol 31, No 3 (2024)
Research Letter
Published online: 2024-05-21
Effectiveness of antazoline versus amiodarone, flecainide, and propafenone in restoring sinus rhythm at the Emergency Department — case-match study
1
, 2, 3
, 2, 3
Abstract
Not available
References
- Hindricks G, Potpara T, Dagres N, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373–498.
- Kalarus Z, Średniawa B, Mitręga K, et al. Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study. Kardiol Pol. 2023; 81(1): 14–21.
- Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013; 112(8): 1142–1147.
- Rozen G, Hosseini S, Kaadan M, et al. Emergency Department Visits for Atrial Fibrillation in the United States: Trends in Admission Rates and Economic Burden From 2007 to 2014. Journal of the American Heart Association. 2018; 7(15).
- Springer J, Szmuda T, Kozłowski D. Does the choice of drug in pharmacologic cardioversion correlate with the guidelines? Systematic review. Advances in Clinical and Experimental Medicine. 2021; 30(3): 331–348.
- Springer J, Pejska M, Homenda W, et al. Effectiveness of antazoline versus amiodarone, flecainide and propafenone in restoring sinus rhythm at the emergency department. Adv Med Sci. 2024 [Epub ahead of print]; 69(2): 248–255.
- Kozłowski D. Method in the Chaos – a step-by-step approach to ECG Interpretation. http://dx.doi.org/10.31373/ejtcm/92255 (28.07.2023).
- Wybraniec MT, Maciąg A, Miśkowiec D, et al. Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study). Pol Arch Intern Med. 2022; 132(6).
